Research output

Safety and immunogenicity of HBAI20 Hepatitis B vaccine in healthy naive and nonresponding adults

Research output: Contribution to journalArticleAcademicpeer-review

Associated researcher

Associated organisations

    Research areas

  • adjuvant, HBAI20, Hepatitis B, immunogenicity, nonresponder, safety, vaccine, CONTROLLED CLINICAL-TRIAL, CHRONIC UREMIC PATIENTS, LOW-DOSE INTERLEUKIN-2, T-CELL-ACTIVATION, RECOMBINANT INTERLEUKIN-2, DENDRITIC CELLS, SURFACE-ANTIGEN, INFLUSOME-VAC, DIFFERENTIATION, EFFICACY
View graph of relations

Details

Original languageEnglish
Pages (from-to)1048-1056
Number of pages9
JournalJournal of Viral Hepatitis
Volume25
Issue number9
DOIs
Publication statusPublished - Sep 2018